BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 17936668)

  • 1. Production of humanized glycoproteins in bacteria and yeasts.
    Chiba Y; Jigami Y
    Curr Opin Chem Biol; 2007 Dec; 11(6):670-6. PubMed ID: 17936668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthetic glycobiology: Exploits in the Golgi compartment.
    Czlapinski JL; Bertozzi CR
    Curr Opin Chem Biol; 2006 Dec; 10(6):645-51. PubMed ID: 17056297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Engineering yeast for producing human glycoproteins: where are we now?
    Laukens B; De Visscher C; Callewaert N
    Future Microbiol; 2015; 10(1):21-34. PubMed ID: 25598335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advances in the production of human therapeutic proteins in yeasts and filamentous fungi.
    Gerngross TU
    Nat Biotechnol; 2004 Nov; 22(11):1409-14. PubMed ID: 15529166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glycan engineering and production of 'humanized' glycoprotein in yeast cells.
    Chiba Y; Akeboshi H
    Biol Pharm Bull; 2009 May; 32(5):786-95. PubMed ID: 19420743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of valuable yeast strains using a novel mutagenesis technique for the effective production of therapeutic glycoproteins.
    Abe H; Takaoka Y; Chiba Y; Sato N; Ohgiya S; Itadani A; Hirashima M; Shimoda C; Jigami Y; Nakayama K
    Glycobiology; 2009 Apr; 19(4):428-36. PubMed ID: 19129247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N-glycosylation humanization for production of therapeutic recombinant glycoproteins in Saccharomyces cerevisiae.
    Arico C; Bonnet C; Javaud C
    Methods Mol Biol; 2013; 988():45-57. PubMed ID: 23475713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of a S. cerevisiae whole cell biocatalyst for in vitro sialylation of oligosaccharides.
    Ryckaert S; Martens V; De Vusser K; Contreras R
    J Biotechnol; 2005 Oct; 119(4):379-88. PubMed ID: 15982773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Engineering of a mammalian O-glycosylation pathway in the yeast Saccharomyces cerevisiae: production of O-fucosylated epidermal growth factor domains.
    Chigira Y; Oka T; Okajima T; Jigami Y
    Glycobiology; 2008 Apr; 18(4):303-14. PubMed ID: 18252777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Challenges in therapeutic glycoprotein production.
    Sethuraman N; Stadheim TA
    Curr Opin Biotechnol; 2006 Aug; 17(4):341-6. PubMed ID: 16828275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycosylation engineering in yeast: the advent of fully humanized yeast.
    Hamilton SR; Gerngross TU
    Curr Opin Biotechnol; 2007 Oct; 18(5):387-92. PubMed ID: 17951046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The humanization of N-glycosylation pathways in yeast.
    Wildt S; Gerngross TU
    Nat Rev Microbiol; 2005 Feb; 3(2):119-28. PubMed ID: 15685223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein glycosylation in diverse cell systems: implications for modification and analysis of recombinant proteins.
    Brooks SA
    Expert Rev Proteomics; 2006 Jun; 3(3):345-59. PubMed ID: 16771706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Yeast made somewhat human to produce human proteins.
    Indian J Exp Biol; 2003 Nov; 41(11):1352. PubMed ID: 15332513
    [No Abstract]   [Full Text] [Related]  

  • 15. Hpf2 glycan structure is critical for protection against protein haze formation in white wine.
    Schmidt SA; Tan EL; Brown S; Nasution UJ; Pettolino F; Macintyre OJ; Lopes Mde B; Waters EJ; Anderson PA
    J Agric Food Chem; 2009 Apr; 57(8):3308-15. PubMed ID: 19301818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biotechnology. Yeast engineered to produce sugared human proteins.
    Service RF
    Science; 2003 Aug; 301(5637):1171. PubMed ID: 12947173
    [No Abstract]   [Full Text] [Related]  

  • 17. Production of mouse monoclonal antibody with galactose-extended sugar chain by suspension cultured tobacco BY2 cells expressing human beta(1,4)-galactosyltransferase.
    Fujiyama K; Furukawa A; Katsura A; Misaki R; Omasa T; Seki T
    Biochem Biophys Res Commun; 2007 Jun; 358(1):85-91. PubMed ID: 17481579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Increase in the yield of recombinant proteins in Saccharomyces cerevisiae yeasts as a result of optimizing their culture conditions].
    Krupnova OF; Sizova NI; Smolianitskiĭ AG
    Prikl Biokhim Mikrobiol; 1995; 31(3):311-5. PubMed ID: 7638157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Engineering of Yeast Glycoprotein Expression.
    De Wachter C; Van Landuyt L; Callewaert N
    Adv Biochem Eng Biotechnol; 2021; 175():93-135. PubMed ID: 30397726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Strategies for humanizing glycosylation pathways and producing recombinant glycoproteins in microbial expression systems.
    Khan AH; Noordin R
    Biotechnol Prog; 2019 Mar; 35(2):e2752. PubMed ID: 30457225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.